Certara is dedicated to improving human health by offering a broad spectrum of software products and services, with special focus on supporting translational approaches to drug development.
Access, visualize, and analyze drug discovery, pre-clinical and clinical data.
Predictive science for drug discovery and other life sciences
Conduct simulations in virtual patient populations based on in vitro and clinical data.
Analyze, manage, report, and validate preclinical and clinical data.
Minimize risks and guide decision making for drug trials.
Assess cardiac safety risks in drug candidates.
Support your strategic drug development decisions and new drug approvals through quantitative analysis and predictive models of diseases, drugs and clinical trials.
Consultancy and guidance on a broad spectrum of DMPK issues, including optimal design for metabolic drug-drug interaction studies, interpretation of data and prediction of in vivo ADME from in vitro studies.
Multi-disciplinary expert scientific team with expertise in pharmacometrics, PK analysis and programming, biostatistics, and medical writing.
Our team of more than 50 scientists has supported over seventeen drug approvals in the last two years.
Search Certara's Resource Library to find papers, presentations, and webinars of interest
Access to some of our resources requires a registered account and "Log In" is required.
Read the latest company announcements, find out about upcoming events where you can meet Certara scientists and representatives, and sign up for upcoming webinars.
From Discovery through Development
November 21, 2014
November 19, 2014
November 03, 2014
All News Articles
Thursday, December 4, 2014
1:00pm - 2:00pm EST
Thursday, December 18, 2014
1:00 - 1:30pm EST
December 1-3, 2014
Legal | Site Map | Contact Us
Copyright © 2011-2014 Certara, L.P., All rights reserved.
210 N. Tucker Blvd, Suite 350, St. Louis MO 63101